Ningbo Menovo Pharm Co Ltd (603538) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Ningbo Menovo Pharm Co Ltd (603538) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥38.86 Million ≈ $5.69 Million USD) by net assets (CN¥2.42 Billion ≈ $353.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ningbo Menovo Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Ningbo Menovo Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Ningbo Menovo Pharm Co Ltd for a breakdown of total debt and financial obligations.

Ningbo Menovo Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo Menovo Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xinxiang Richful Lube Additive Co. Ltd SHE:300910	0.093x
Hunan Kaimeite Gases Co Ltd SHE:002549	0.034x
Entra ASA OL:ENTRA	0.054x
Chongqing Sanfeng Environment Group Corp Ltd SHG:601827	0.081x
Spartan Resources Ltd AU:SPR	-0.015x
Vanchip (Tianjin) Technology Co. Ltd. A SHG:688153	N/A
SVG Optronics Co Ltd SHE:300331	0.031x
Nantong Haixing Electronics Co Ltd SHG:603115	0.000x

Annual Cash Flow Conversion Efficiency for Ningbo Menovo Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Ningbo Menovo Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Ningbo Menovo Pharm Co Ltd (603538) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.29 Billion ≈ $335.31 Million	CN¥97.54 Million ≈ $14.27 Million	0.043x	+918.66%
2023-12-31	CN¥2.19 Billion ≈ $319.83 Million	CN¥9.13 Million ≈ $1.34 Million	0.004x	-96.72%
2022-12-31	CN¥2.17 Billion ≈ $318.01 Million	CN¥276.95 Million ≈ $40.53 Million	0.127x	+14.28%
2021-12-31	CN¥1.98 Billion ≈ $289.52 Million	CN¥220.63 Million ≈ $32.28 Million	0.112x	-21.89%
2020-12-31	CN¥1.76 Billion ≈ $257.91 Million	CN¥251.61 Million ≈ $36.82 Million	0.143x	+24.57%
2019-12-31	CN¥1.57 Billion ≈ $229.52 Million	CN¥179.75 Million ≈ $26.30 Million	0.115x	+229.61%
2018-12-31	CN¥1.34 Billion ≈ $196.11 Million	CN¥46.60 Million ≈ $6.82 Million	0.035x	-49.57%
2017-12-31	CN¥1.16 Billion ≈ $170.11 Million	CN¥80.15 Million ≈ $11.73 Million	0.069x	-57.01%
2016-12-31	CN¥731.02 Million ≈ $106.97 Million	CN¥117.24 Million ≈ $17.16 Million	0.160x	-22.37%
2015-12-31	CN¥645.81 Million ≈ $94.50 Million	CN¥133.42 Million ≈ $19.52 Million	0.207x	+55.00%
2014-12-31	CN¥564.34 Million ≈ $82.58 Million	CN¥75.22 Million ≈ $11.01 Million	0.133x	-56.46%
2013-12-31	CN¥487.44 Million ≈ $71.33 Million	CN¥149.21 Million ≈ $21.83 Million	0.306x	+255.52%
2012-12-31	CN¥442.58 Million ≈ $64.76 Million	CN¥38.11 Million ≈ $5.58 Million	0.086x	-73.22%
2011-12-31	CN¥378.47 Million ≈ $55.38 Million	CN¥121.67 Million ≈ $17.80 Million	0.321x	--

About Ningbo Menovo Pharm Co Ltd

SHG:603538 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.01 Billion

CN¥13.77 Billion CNY

Market Cap Rank

#6227 Global

#1366 in China

Share Price

CN¥62.46

Change (1 day)

-4.35%

52-Week Range

CN¥13.71 - CN¥65.30

All Time High

CN¥65.30